Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Biochimie ; 82(4): 365-73, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10865124

RESUMEN

Catecholamine secretion from chromaffin cells has been used for a long time as a general model to study exocytosis of large dense core secretory granules. Permeabilization and microinjection techniques have brought the possibility to dissect at the molecular level the multi-protein machinery involved in this complex physiological process. Regulated exocytosis comprises distinct and sequential steps including the priming of secretory granules, the formation of a docking complex between granules and the plasma membrane and the subsequent fusion of the granule with the plasma membrane. Key proteins involved in the exocytotic machinery have been identified. For instance, SNAREs which participate in the docking events in most intracellular transport steps along the secretory pathway, play a role in exocytosis in both neuronal and endocrine cells. However, in contrast to intracellular transport processes for which the highest fusion efficiency is required after correct targeting of the vesicles, the number of exocytotic events in activated secretory cells needs to be tightly controlled. We describe here the multistep control exerted by heterotrimeric and monomeric G proteins on the progression of secretory granules from docking to fusion and the molecular nature of some of their downstream effectors in neuroendocrine chromaffin cells.


Asunto(s)
Células Cromafines/fisiología , Exocitosis/fisiología , Proteínas de Unión al GTP Heterotriméricas/metabolismo , Proteínas de Unión al GTP Monoméricas/metabolismo , Actinas/fisiología , Actinas/ultraestructura , Animales , Gránulos Cromafines/fisiología , Fusión de Membrana , Proteínas del Tejido Nervioso/metabolismo , Transducción de Señal
2.
J Biol Chem ; 273(3): 1373-9, 1998 Jan 16.
Artículo en Inglés | MEDLINE | ID: mdl-9430671

RESUMEN

The ADP-ribosylation factor (ARF) GTP-binding proteins have been implicated in a wide range of vesicle transport and fusion steps along the secretory pathway. In chromaffin cells, ARF6 is specifically associated with the membrane of secretory chromaffin granules. Since ARF6 is an established regulator of phospholipase D (PLD), we have examined the intracellular distribution of ARF6 and PLD activity in resting and stimulated chromaffin cells. We found that stimulation of intact chromaffin cells or direct elevation of cytosolic calcium in permeabilized cells triggered the rapid translocation of ARF6 from secretory granules to the plasma membrane and the concomitant activation of PLD in the plasma membrane. To probe the existence of an ARF6-dependent PLD in chromaffin cells, we measured the PLD activity in purified plasma membranes. PLD could be activated by a nonhydrolyzable analogue of GTP and by recombinant myristoylated ARF6 and inhibited by specific anti-ARF6 antibodies. Furthermore, a synthetic myristoylated peptide corresponding to the N-terminal domain of ARF6 inhibited both PLD activity and catecholamine secretion in calcium-stimulated chromaffin cells. The possibility that ARF6 participates in the exocytotic reaction by controlling a plasma membrane-bound PLD and thereby generating fusogenic lipids at the exocytotic sites is discussed.


Asunto(s)
Proteínas Portadoras/metabolismo , Células Cromafines/citología , Exocitosis , Proteínas de Unión al GTP/metabolismo , Fosfolipasa D/metabolismo , 1-Butanol/farmacología , Factores de Ribosilacion-ADP , Animales , Calcio/metabolismo , Bovinos , Membrana Celular/enzimología , Células Cultivadas , Células Cromafines/efectos de los fármacos , Activación Enzimática , Etanol/farmacología , Guanosina 5'-O-(3-Tiotrifosfato)/metabolismo
3.
J Biol Chem ; 275(21): 15637-44, 2000 May 26.
Artículo en Inglés | MEDLINE | ID: mdl-10748097

RESUMEN

ADP-ribosylation factors (ARFs) constitute a family of structurally related proteins that forms a subset of the Ras superfamily of regulatory GTP-binding proteins. Like other GTPases, activation of ARFs is facilitated by specific guanine nucleotide exchange factors (GEFs). In chromaffin cells, ARF6 is associated with the membrane of secretory granules. Stimulation of intact cells or direct elevation of cytosolic calcium in permeabilized cells triggers the rapid translocation of ARF6 to the plasma membrane and the concomitant activation of phospholipase D (PLD) in the plasma membrane. Both calcium-evoked PLD activation and catecholamine secretion in permeabilized cells are strongly inhibited by a synthetic peptide corresponding to the N-terminal domain of ARF6, suggesting that the ARF6-dependent PLD activation near the exocytotic sites represents a key event in the exocytotic reaction in chromaffin cells. In the present study, we demonstrate the occurrence of a brefeldin A-insensitive ARF6-GEF activity in the plasma membrane and in the cytosol of chromaffin cells. Furthermore, reverse transcriptase-polymerase chain reaction and immunoreplica analysis indicate that ARNO, a member of the brefeldin A-insensitive ARF-GEF family, is expressed and predominantly localized in the cytosol and in the plasma membrane of chromaffin cells. Using permeabilized chromaffin cells, we found that the introduction of anti-ARNO antibodies into the cytosol inhibits, in a dose-dependent manner, both PLD activation and catecholamine secretion in calcium-stimulated cells. Furthermore, co-expression in PC12 cells of a catalytically inactive ARNO mutant with human growth hormone as a marker of secretory granules in transfected cells resulted in a 50% inhibition of growth hormone secretion evoked by depolarization with high K(+). The possibility that the plasma membrane-associated ARNO participates in the exocytotic pathway by activating ARF6 and downstream PLD is discussed.


Asunto(s)
Factores de Ribosilacion-ADP/metabolismo , Membrana Celular/metabolismo , Células Cromafines/metabolismo , Proteínas Activadoras de GTPasa/metabolismo , Factores de Intercambio de Guanina Nucleótido/metabolismo , Factor 6 de Ribosilación del ADP , Glándulas Suprarrenales/efectos de los fármacos , Glándulas Suprarrenales/metabolismo , Animales , Anticuerpos/farmacología , Brefeldino A/farmacología , Calcio/farmacología , Catecolaminas/metabolismo , Bovinos , Gránulos Citoplasmáticos/efectos de los fármacos , Gránulos Citoplasmáticos/metabolismo , Citosol/metabolismo , Activación Enzimática/efectos de los fármacos , Exocitosis/efectos de los fármacos , Proteínas Activadoras de GTPasa/genética , Células PC12 , Fragmentos de Péptidos/farmacología , Fosfolipasa D/metabolismo , ARN Mensajero/metabolismo , Ratas
4.
EMBO J ; 20(10): 2424-34, 2001 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-11350931

RESUMEN

Phospholipase D (PLD) has been proposed to mediate cytoskeletal remodeling and vesicular trafficking along the secretory pathway. We recently described the activation of an ADP ribosylation factor-regulated PLD at the plasma membrane of chromaffin cells undergoing secretagogue-stimulated exocytosis. We show here that the isoform involved is PLD1b, and, using a real-time assay for individual cells, that PLD activation and exocytosis are closely correlated. Moreover, overexpressed PLD1, but not PLD2, increases stimulated exocytosis in a phosphatidylinositol 4,5-bisphosphate-dependent manner, whereas catalytically inactive PLD1 inhibits it. These results provide the first direct evidence that PLD1 is an important component of the exocytotic machinery in neuroendocrine cells.


Asunto(s)
Células Cromafines/enzimología , Exocitosis/fisiología , Fosfolipasa D/metabolismo , Actinas/metabolismo , Animales , Catálisis , Bovinos , Células Cultivadas , Células Cromafines/citología , Células Cromafines/fisiología , Inhibidores Enzimáticos/farmacología , Líquido Intracelular/enzimología , Isoenzimas/antagonistas & inhibidores , Isoenzimas/metabolismo , Sistemas Neurosecretores/citología , Células PC12 , Fosfatidilinositol 4,5-Difosfato/metabolismo , Fosfolipasa D/antagonistas & inhibidores , Proteína Quinasa C/metabolismo , Ratas , Esfingosina/análogos & derivados , Esfingosina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA